Skip to main content
. Author manuscript; available in PMC: 2014 May 1.
Published in final edited form as: J Pediatr Hematol Oncol. 2013 May;35(4):289–298. doi: 10.1097/MPH.0b013e31828d5e6a

Table 3.

Demographic Characteristics of Focus Group Participants by Site

Characteristics Chicago
N=9
% (n)
Dallas
N=11
% (n)
Atlanta
N=31
% (n)
Total
N=51
% (n)
Gender Female 55.5 (5) 63.6 (7) 77.4 (26) 74.5 (38)
Male 44.5 (4) 36.4 (4) 16.1 (5) 25.5 (13)
Focus Group Adult 55.5 (5) 81.8 (9) 87.1 (27) 80.4 (41)
Youth 44.5 (4) 18.2 (2) 12.9 (4) 19.6 (10)
Child’s Type of SCD SS (HbSS) 22.2 (2) 72.7 (8) 74.2 (23) 64.7 (33)
SC (HbSC) 11.2 (1) - 16.1 (5) 13.7 (7)
Sβ-thalassemia 22.2 (2) - 9.7 (3) 9.8 (5)
Unknown 44.4 (4) 27.3 (3) - 11.8 (6)
Number of Episodes* Last Year 0–1 11.1 (1) - - 2.0 (1)
2–5 66.7 (6) 81.8 (9) 61.3 (19) 66.7 (34)
6–10 - 9.1 (1) 25.8 (8) 17.6 (9)
11 or more 22.2 (2) 9.1 (1) 12.9 (4) 13.7 (7)
Employment Status (Participant) Employed 66.7 (6) 90.9 (10) 71.0 (22) 74.5 (38)
Unemployed 33.3 (3) 9.1 (1) 29.0 (9) 25.5 (13)
Employment Status (Partner/Youth’s Father) Employed 44.4 (4) 18.2 (2) 51.6 (16) 43.1 (22)
Unemployed - - 6.5 (2) 4.0 (2)
Other 55.6 (5) 81.8 (9) 41.9 (13) 52.9 (27)
Insurance Status Insured 100.0 (9) 100.0 (11) 96.8 (30) 98.0 (50)
Uninsured - - 3.2 (1) 2.0 (1)
Distance from Medical Facility (miles) 1–30 100.0 (9) 81.8 (9) 74.2 (23) 80.4 (41)
31–60 - 18.2 (2) 22.6 (7) 17.6 (9)
More than 60 - - 3.2 (1) 2.0 (1)
*

Number of times child was hospitalized or had to seek treatment from any clinical settings for complications due to sickle cell disease (SCD) such as pain crisis, respiratory problems, stroke, etc.